The blood pump developer raised $16.3m from public investment bank BPIfrance, following a Novo Seeds-backed round two years ago.

CorWave, a France-based medical technology developer that counts pharmaceutical firm Novo as an investor, has received €14m ($16.3m) from BPIfrance, the public investment bank of France.

Founded in 2011, CorWave is using wave membrane technology to develop blood pumps that copy cardiac beating to preserve blood. The BPIfrance investment will help fund the €25m research program it has instituted for its CorWave Neptune device.

The company emerged out of incubator MD Start and raised an undisclosed amount of series A…